Abstract
Gastric cancer (GC) is the fifth most common and fourth most lethal cancer worldwide, with 768,793 deaths in 2020. The patients’ prognosis and survival can be significantly improved by early screening and detection. While endoscopy serves as the gold standard for GC diagnosis and provides sufficient diagnostic power for identifying GC in early stages, this invasive method is costly and of limited feasibility for screening with poor compliance in developing countries with high GC incidence and large populations, e.g., China.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
